# Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction

Study · id `cardio:ct-nct07560436` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07560436](<https://clinicaltrials.gov/study/NCT07560436>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07560436

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

## Technical summary

Registry record NCT07560436. Randomized; double masking; primary purpose treatment. Start 2026-03-23 (actual); primary completion 2028-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 350 participants (planned count; ClinicalTrials.gov record NCT07560436, source copy `cardio:ctgov-nct07560436-2026-05-01`, retrieved 2026-10-26)
- Started: 2026-03-23 (actual) (ClinicalTrials.gov record NCT07560436, source copy `cardio:ctgov-nct07560436-2026-05-01`, retrieved 2026-10-26)
- Primary completion: 2028-11 (anticipated) (ClinicalTrials.gov record NCT07560436, source copy `cardio:ctgov-nct07560436-2026-05-01`, retrieved 2026-10-26)
- Completion: 2029-08 (anticipated) (ClinicalTrials.gov record NCT07560436, source copy `cardio:ctgov-nct07560436-2026-05-01`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT07560436, source copy `cardio:ctgov-nct07560436-2026-05-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07560436-2026-05-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction
- Acronym: REPRIEVED
- Condition: Heart Failure With Preserved Ejection Fraction (HFPEF)
- Condition: Coronary Artery Disease
- Intervention (Procedure): Percutaneous coronary intervention
- Intervention (Other): Placebo procedure
- Lead sponsor: King's College London
- Lead sponsor class: OTHER
- Collaborator: Guy's and St Thomas' NHS Foundation Trust
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: King's College London (`cardio:org-king-s-college-london`)
- Registry lists this organization as a collaborator: Guy's and St Thomas' NHS Foundation Trust (`cardio:org-guy-s-and-st-thomas-nhs-foundation-trust`)

## Provenance

Content hash: 1a88b2c9ccb23fe0493b1e7fb413396d8ecd84e0ba42bab490ff28e7afad5af4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
